SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes

Clinical trial NCT03982381 · COMPLETED

Trial details

NCT number: NCT03982381
Sponsor: Uppsala University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2019-09-05
Primary completion: 2026-01-31
Enrollment: 2067

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.